Therapeutic opportunities for liver X receptor modulators

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Liver X receptors (LXRs), including LXRalpha and LXRbeta, are nuclear receptors controlling lipid metabolism.
• LXRs are validated drug targets for cardiovascular diseases.
• Emerging research highlights LXR ligands for treating inflammation, diabetes, and neurodegenerative conditions.

Purpose of the Study:

• To review the effects of LXR agonists on signaling pathways.
• To discuss recent ligand-bound LXR crystal structures.
• To present novel LXR small-molecule templates.

Main Methods:

• Literature review of LXR agonist effects.
• Analysis of recent crystallographic studies on LXR.
• Compilation of recently disclosed LXR small-molecule templates.

Main Results:

• LXR agonists impact diverse signaling pathways relevant to multiple diseases.
• Structural insights into ligand-bound LXRs are advancing drug design.
• A range of small-molecule LXR templates have been identified.

Conclusions:

• LXR agonists represent a promising therapeutic strategy beyond cardiovascular disease.
• Further research into LXR pathways and ligand development is warranted.
• LXR-targeted therapies hold potential for treating inflammatory, metabolic, and neurological disorders.